AP NEWS

Zensights Names Dan Henry as Chief Innovation Officer

October 1, 2018

SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Oct 1, 2018--Zensights is pleased to announce that Dan Henry has joined the organization as Chief Innovation Officer. In his new role, Mr. Henry will lead the organization’s vision and execution of providing an outstanding user experience for Linx™ the proprietary vendor analysis software tool that provides “Best in Class” insights regarding vendors supporting the pharmaceutical industry. He will be tasked with accelerating the utilization and product development of Linx™ as new applications are released to support the growing Zensights customer base. Linx™ provides an independent view of a vendor’s effectiveness, on a capability by capability basis, for a wide range of services supporting the biopharmaceutical industry.

Mr. Henry has extensive pharmaceutical management expertise with foundational skills developed at GlaxoSmithKline. As many senior pharmaceutical leaders have started in a sales capacity, Mr. Henry is no exception. His career rapidly advanced from the field to in-house training, to brand leadership including leading a portfolio of OTC brands for the Asia – Pacific and Latin America markets. Additional career responsibilities included Otsuka America Pharmaceuticals, where he led the marketing efforts for the Digital Medicine group. His experiences were further enhanced as the Life Sciences Managing Director for Outcome Health. During this role, he worked with life sciences companies to help innovate and involve their marketing efforts to meet the needs of today’s healthcare environment.

Mr. Henry has a deep pharmaceutical, consumer healthcare and digital health background which makes him uniquely qualified for the Chief Innovation Officer’s responsibility for Zensights. He earned his Bachelor of Arts – Communication from the University of Delaware and his Master’s in Strategic Communications from Seton Hall University. Mr. Henry and his family live in Spring Lake, N.J.

Bob Jansen, CEO of Zensights stated, “Dan brings a wealth of digital expertise, specifically geared to the biopharmaceutical industry. With digital expertise at both the client level and also a transformational company like Outcome Health, Dan is well qualified to lead the digital strategy for Zensights. Dan complements our existing senior leadership team and will be instrumental in the future product development of Linx™. We are thrilled to have Dan join Zensights.”

About Zensights

Zensights is a pharmaceutical vendor management company focused on making the complex world of vendor selection easier for the BioPharma manufacturer. Zensights’ signature software tool Linx™ analyzes, aggregates, and provides an overall market assessment of the capabilities of third-party vendors that service the bio-tech, pharmaceutical, and life sciences industries. The proprietary tool is populated with key decision maker and budget holder feedback to easily and strategically orchestrate RFP and RFI from the highest-rated vendors servicing the BioPharma Industry.

View source version on businesswire.com:https://www.businesswire.com/news/home/20181001005611/en/

CONTACT: Duane Morris LLP

Amy Abbonizio, 215-979-7376

alabbonizio@duanemorris.com

KEYWORD: UNITED STATES NORTH AMERICA ARIZONA

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY PHARMACEUTICAL MANUFACTURING OTHER MANUFACTURING PROFESSIONAL SERVICES OTHER PROFESSIONAL SERVICES

SOURCE: Zensights

Copyright Business Wire 2018.

PUB: 10/01/2018 09:58 AM/DISC: 10/01/2018 09:58 AM

http://www.businesswire.com/news/home/20181001005611/en

AP RADIO
Update hourly